Patent Assignment
Reel/Frame 059357/0105
Change of Name
Recorded: 2022-03-09
Pages: 2
Assignor
BIOTIME, INC.
Executed: 2019-08-09
Assignee
LINEAGE CELL THERAPEUTICS, INC.
2173 SALK AVENUE, SUITE 200, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(3)
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,992 →
Publication:
US 2022/0160833
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,997 →
Publication:
US 2022/0088137
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/543,020 →
Publication:
US 2022/0088138
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059213/0084 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 059213/0272 →
Assignment of Assignor's Interest
Mar 11, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059242/0007 →
Security Interest
Nov 10, 2023
From: AGEX THERAPEUTICS, INC.; RECYTE THERAPEUTICS, INC.; REVERSE BIOENGINEERING, INC.
To: JUVENESCENCE LIMITED
Reel/Frame 065529/0594 →